"10.1371_journal.pone.0135805","plos one","2015-08-14T00:00:00Z","Ana Beatriz Vargas-Santos; Geraldo da Rocha Castelar-Pinheiro; Evandro Silva Freire Coutinho; H Ralph Schumacher; Jasvinder A Singh; Naomi Schlesinger","Division of Rheumatology, Internal Medicine Department, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; Epidemiology Department, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil; Division of Rheumatology, University of Pennsylvania School of Medicine and Veterans Affairs Medical Center, Philadelphia, Pennsylvania, United States of America; Medicine Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, United States of America; Department of Medicine at the School of Medicine, and the Division of Epidemiology at School of Public Health, University of Alabama, Birmingham, Alabama, United States of America; Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America; Division of Rheumatology, Department of Medicine, Rutgers–Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America","Conceived and designed the experiments: ABVS GRCP ESFC HRSJ JAS NS. Performed the experiments: ABVS GRCP. Analyzed the data: ABVS GRCP ESFC HRSJ JAS NS. Contributed reagents/materials/analysis tools: ABVS GRCP ESFC HRSJ NS. Wrote the paper: ABVS GRCP ESFC HRSJ JAS NS.","Ana Beatriz Vargas-Santos has received consultant fee from Astrazeneca; H. Ralph Schumacher Jr. has received research grants from Abbvie and Takeda, and consultant fees from Abbvie, Ardea, AstraZeneca, Merck, Metabolex, Novartis Pharmaceutical Corporation, Regeneron and Takeda; Jasvinder A. Singh has received research and travel grants from Takeda and Savient, and consultant fees from Savient, Takeda, Allergan and Regeneron; Naomi Schlesinger has received grants from Novartis Pharmaceutical Corporation, consultant fees from Novartis Pharmaceutical Corporation, Sobi, BMS, is on the Speakers’ Bureau of Novartis Pharmaceutical Corporation and Takeda, and serves on the advisory boards of Novartis Pharmaceutical Corporation, Takeda and Sobi. Jasvinder A. Singh is also supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs), National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute of Aging (NIA) and National Cancer Institute (NCI). Geraldo da Rocha Castelar-Pinheiro and Evandro Silva Freire Coutinho have declared that no competing interests exist. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2015","08","Ana Beatriz Vargas-Santos","ABVS",6,FALSE,6,2,6,6,TRUE,TRUE,TRUE,1,"4",FALSE
